Literature DB >> 8651354

Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations.

M Cuatrecasas1, X Matias-Guiu, J Prat.   

Abstract

Mucinous tumors of the ovary are often associated with mucinous tumors of the appendix. It has not been clearly determined whether they are independent or metastatic neoplasms. A clinicopathologic study and a comparative analysis of c-Ki-ras mutations were done in six cases of synchronous ovarian and appendiceal tumors. The clinicopathologic features (simultaneous presentation, bilaterality or right-sided predominance, similar histopathologic findings, presence of pseudomyxoma peritonei) suggested that they were primary appendiceal tumors metastatic to the ovaries. DNA was extracted from formalin-fixed, paraffin-embedded tissue, and target sequences were amplified in vitro by the polymerase chain reaction. Mutations were detected by the presence of restriction fragment length polymorphism, artificially introduced by the use of mutant amplimers. The pattern of c-Ki-ras mutations was identical in the ovarian and appendiceal tumors of all patients. Four patients had a GGT --> GAT (Gly --> Asp) transition and one a GGT --> GTT (Gly --> Val) transversion, all detected in codon 12. No mutation was found in the sixth patient in either the ovarian or the appendiceal tumor. Because c-Ki-ras mutations are considered to represent an early event in tumorigenesis, our results support a clonal nature for both tumors and suggest that they are not independent tumors but rather originate one from another.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651354     DOI: 10.1097/00000478-199606000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

1.  Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis.

Authors:  X Matias-Guiu
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Controversial origin of Pseudomyxoma peritonei.

Authors:  Alejandro Rojo Sebastián; Francisco José Fernández Morejón; Pedro Bretcha Boix; José Farré Alegre; Jerónimo Forteza Vila; Antonio Brugarolas Masllorens
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

3.  Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.

Authors:  Kevin M Elias; S Intidhar Labidi-Galy; Allison F Vitonis; Jason L Hornick; Leona A Doyle; Michelle S Hirsch; Daniel W Cramer; Ronny Drapkin
Journal:  Gynecol Oncol       Date:  2013-12-14       Impact factor: 5.482

4.  Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.

Authors:  C Szych; A Staebler; D C Connolly; R Wu; K R Cho; B M Ronnett
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  Pathophysiology and biology of peritoneal carcinomatosis.

Authors:  Shigeki Kusamura; Dario Baratti; Nadia Zaffaroni; Raffaella Villa; Barbara Laterza; Maria Rosaria Balestra; Marcello Deraco
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

Review 6.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

7.  Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.

Authors:  Jerome T O'Connell; James S Tomlinson; Alice A Roberts; Kathryn F McGonigle; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Prognostic significance of ras/p21 alterations in human ovarian cancer.

Authors:  G Scambia; V Masciullo; P Benedetti Panici; M Marone; G Ferrandina; N Todaro; A Bellacosa; S K Jain; G Neri; A Piffanelli; S Mancuso
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype.

Authors:  Kjersti Flatmark; Wenche Reed; Thomas Halvorsen; Olaf Sørensen; Johan N Wiig; Stein G Larsen; Øystein Fodstad; Karl-Erik Giercksky
Journal:  BMC Cancer       Date:  2007-06-30       Impact factor: 4.430

10.  Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.

Authors:  K Nakayama; Y Takebayashi; K Hata; R Fujiwaki; K Iida; M Fukumoto; K Miyazaki
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.